Karen Yun

Title(s)	Assistant Clinical Professor, Medicine
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma. Cancers (Basel). 2024 Mar 22; 16(7). Yun KM, Bazhenova L. PMID: 38610930; PMCID: PMC11011044.

View in: PubMed Mentions:
An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer. JCO Oncol Pract. 2024 Mar 07; OP2300747. Yun KM, Cohen EEW. PMID: 38452309.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome. JCO Precis Oncol. 2024 Jan; 8:e2300265. Yun KM, Narezkina A, Redfern C, Velasco K, Bazhenova L. PMID: 38271657; PMCID: PMC10830087.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Metastatic HER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan. BMJ Case Rep. 2023 May 08; 16(5). Yun KM, Bazhenova L. PMID: 37156567; PMCID: PMC10173996.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans
Management of toxicities associated with immune checkpoint inhibitors. Clin Adv Hematol Oncol. 2023 Mar; 21(3):142-149. Yun KM, Bazhenova L. PMID: 36867558.

View in: PubMed Mentions: Fields:
Hem Hematology Neo Neoplasms
Translation:Humans
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity. Curr Treat Options Oncol. 2022 09; 23(9):1153-1168. Bylsma S, Yun K, Patel S, Dennis MJ. PMID: 35876957; PMCID: PMC9402751.

View in: PubMed Mentions: 5 Fields:
Neo Neoplasms
Translation:Humans
Update on Lorlatinib: Role in Reducing the Risk of Disease Progression in ALK-Positive NSCLC. Cancer Manag Res. 2022; 14:843-850. Yun KM, Bazhenova LA. PMID: 35250311; PMCID: PMC8890401.

View in: PubMed Mentions: 3
Rapid onset type 1 diabetes with anti-PD-1 directed therapy. Oncotarget. 2020 Jul 14; 11(28):2740-2746. Yun K, Daniels G, Gold K, Mccowen K, Patel SP. PMID: 32733645; PMCID: PMC7367652.

View in: PubMed Mentions: 8 Fields:
Neo Neoplasms
Women in Emergency Medicine Residency Programs: An Analysis of Data From Accreditation Council for Graduate Medical Education-approved Residency Programs. AEM Educ Train. 2017 Jul; 1(3):175-178. DeFazio CR, Cloud SD, Verni CM, Strauss JM, Yun KM, May PR, Lindstrom HA. PMID: 30051031; PMCID: PMC6001616.

View in: PubMed Mentions: 9